[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance

• Authors:
  • Beige Zong
  • Lu Sun
  • Yang Peng
  • Yihua Wang
  • Yu Yu
  • Jinwei Lei
  • Yingzi Zhang
  • Shipeng Guo
  • Kang Li
  • Shengchun Liu

• View Affiliations

  
  Affiliations: Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China, Department of Pathology, Chongqing Medical University, Chongqing 400015, P.R. China, Chongqing City Key Lab of Translational Medical Research in Cognitive Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
• Published online on: July 19, 2021     https://doi.org/10.3892/or.2021.8146
• Article Number: 195

• Copyright : © Zong et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1